NCT02160639 Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support Status UNKNOWN Phase NA
NCT02159365 Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Status COMPLETED Phase PHASE2
NCT02159352 Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants Status COMPLETED Phase PHASE1
NCT02157506 A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure Status COMPLETED Phase PHASE2
NCT02156804 A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172) Status COMPLETED Phase PHASE2
NCT02156076 A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation Status TERMINATED Phase PHASE2
NCT02153437 Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers Status TERMINATED Phase PHASE1
NCT02142218 Expanded Access Program With Nivolumab to Treat Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02134288 Belatacept for Renal Transplant Recipients With Delayed Graft Function Status TERMINATED Phase EARLY_PHASE1
NCT02130817 Belatacept in Kidney Transplantation of Moderately Sensitized Patients Status WITHDRAWN Phase PHASE4
NCT02124044 Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV Status COMPLETED Phase PHASE2
NCT02123654 UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C Status COMPLETED Phase PHASE3
NCT02115139 GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases Status COMPLETED Phase PHASE2
NCT02113657 T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02110082 Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02109666 Long Term Experience With Abatacept in Routine Clinical Practice Status COMPLETED Phase N/A
NCT02108860 Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Status COMPLETED Phase PHASE3